European Medicines Agency: More than 300 cases of rare blood clot events worldwide
The exterior of the European Medicines Agency is seen in Amsterdam, Netherlands, December 18, 2020. REUTERS/Piroschka van de Wouw/File Photo
Register now for FREE unlimited access to Reuters.com
AMSTERDAM, April 20 (Reuters) - The European Union’s drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of COVID-19 vaccines.
There were 287 occurrences with the AstraZeneca vaccine, eight with Johnson & Johnson’s shot, 25 for Pfizer and five for Moderna, said Peter Arlett, Head of Data Analytics at the European Medicines Agency (EMA).
Register now for FREE unlimited access to Reuters.com
Our Standards: The Thomson Reuters Trust Principles.